Moneyta · stock research · no sign-up needed
DXCM
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q2 FY2026)
$1.3B
+26.3% y/y
Net income (Q2 FY2026)
$249M
as filed with the SEC
Institutions holding
979
+12 last quarter
Overview · DEXCOM INC
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monito…
Management team
- Mr. Steven R. Pacelli · Executive VP & MD of Dexcom VenturesFind on LinkedIn
- Ms. Sadie M. Stern · Executive VP & Chief Human Resources OfficerFind on LinkedIn
- Mr. Matthew Dolan · Executive Vice President of Strategy, Corporate Development & Dexcom LabsFind on LinkedIn
- Mr. Sean Christensen · Director of Corporate Affairs & Head of Investor RelationsFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on DXCM
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.